You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Personal Alcohol Management System: PALMS mobile platform for alcohol use disorders

    SBC: VisionQuest Biomedical Inc            Topic: 350

    DESCRIPTION provided by applicant Alcohol misuse is a significant public health problem not only in the US but around the world Just in the US alcohol misuse is estimated to be the second cause of preventable death at a cost of more than $ billion in a single year Further it is also estimated that it reduces the lives of those who died by years Screening and brief interventions have ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  2. NMDA RECEPTOR MODULATORS AS NOOTROPIC THERAPIES IN AGING BRAIN

    SBC: Aptinyx Inc            Topic: NIA

    DESCRIPTION provided by applicant Age related memory loss is a growing public health issue which will be magnified in the coming decades by increasing life expectancies and the aging baby boomer population Age is the most important risk factor for developing dementia of the population between and has some form of dementia between and and of those or older The the ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  3. Development of a tool for the whole genome de novo assembly of hepatitis B virus (HBV) populations

    SBC: GATACA LLC            Topic: NIAID

    DESCRIPTION provided by applicant Hepatitis infection is a widespread and persistent crisis both in the U S and worldwide Chronic infection with the hepatitis B virus HBV is a major cause of end stage liver disease with staggering long term healthcare costs Thus HBV research and innovation have been deemed national priorities in the U S as evidenced by calls to action by the Institute ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  4. Peptide inhibition of complement-mediated hemolysis after xenotransfusion.

    SBC: Childrens Specialty Group PLLC            Topic: NIAID

    DESCRIPTION provided by applicant The hypothesis for this project is that a novel compound Peptide Inhibitor of complement C PIC will inhibit antibody initiated complement mediated cell destruction in a xenotransfusion animal model Complement is the most potent inflammatory cascade in humans and is initiated by antibodies driving classical pathway activation and host cell destruction in ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  5. Targeting galectin-3 for prostate cancer therapy

    SBC: GLYCOMANTRA INC            Topic: NCI

    DESCRIPTION provided by applicant Galectin a beta galactoside binding lectin is involved in the progression of many cancers In our recent publication in PNAS PMC we have shown that in prostate cancer galectin promotes tumor angiogenesis tumor endothelial cell adhesion and metastasis and also evades immune surveillance through killing of infiltrating T cells To block galecti ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  6. Transcutaneous Neuromodulation at Acupoint for Gastric Complications of Scleroderma

    SBC: TRANSTIMULATION RESEARCH INC            Topic: R

    DESCRIPTION provided by applicant Systemic sclerosis scleroderma SSc is a chronic autoimmune disease characterized by proliferative vascular lesions with resultant fibrosis of skin and other multiple organs including the gastrointestinal GI tract In the United States the prevalence of SSc is about per million in adults Up to of SSc patients are reported to have upper and lower ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  7. Screening for pancreatic cancer via nanocytology of duodenal cells

    SBC: NANOCYTOMICS LLC            Topic: NCI

    DESCRIPTIONprovided by applicantThe goal of this SBIR project is to develop a minimally intrusivehighly sensitive risk stratification tool to determine the need for invasive pancreatic cancerPCscreeningPC is theth leading cause of cancer deaths in the USWhile early stage disease is generally curablethe vast majority of patients are diagnosed in advancedunresectable stages due in large part to the ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  8. A Holographic Waveguide Display Based Low Vision Eyewear

    SBC: BIOLIGHT ENGINEERING LLC            Topic: N

    DESCRIPTION provided by applicant Low vision rehabilitation is the only proven way to restore functional vision and maintain a high quality of life in patients with permanent vision impairment Low vision aids are devices that manipulate visual information for example magnify images to compensate for impaired vision The patientandapos s willingness to accept a low vision aid ability to ada ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  9. Development Novel Acoustic Processing for Cryoprotectant Removal and Cell Enrichment in Cellular Therapy

    SBC: Acoustic Biosystems, Inc.            Topic: 400

    DESCRIPTION provided by applicant Nine cell therapy products having a $ $ million market size have been approved for use in the United States or EU With the anticipated approval of additional products the cell therapy market is expected to grow at an annualized rate of greater than through the remainder of the decade Creation of cell therapy products employ four unit operatio ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  10. Simultaneous Multifunction Control of Powered Upper-Limb Prostheses

    SBC: Coapt LLC            Topic: NICHD

    DESCRIPTION provided by applicant Pattern recognition PR myoelectric control systems can dramatically improve an amputee patientandapos s control of a powered prosthesis but they still require that the user perform sequential movements to achieve a task Coapt LLC is an early stage company that has initiated a controlled commercial release of PR myoelectric control for the benefit of upper ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government